Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)

Clinical trial NCT07567131 · RECRUITING

Trial details

NCT number: NCT07567131
Sponsor: Portal Therapeutics, Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Erythropoietic Protoporphyria (EPP)X-Linked Porphyria (XLP)

Start date: 2026-04-30
Primary completion: 2027-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.